Overview

Flupenthixol Decanoate in Methamphetamine Smoking - 1

Status:
Completed
Trial end date:
1996-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of flupenthixol decanoate for treatment of methamphetamine dependence. Also, study will compare flupenthixol with desipramine in blocking methamphetamine self-administration.
Phase:
Phase 2
Details
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Collaborator:
Friends Research Institute, Inc.
Treatments:
Decanoic acid
Flupenthixol
Flupenthixol decanoate
Methamphetamine